Clinical Trial Update: Treatment of Hemochromatosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for the treatment of Hemochromatosis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemochromatosis

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Hemochromatosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING